BMJ7d
Forecasting cardiovascular disease risk and burden in China from 2020 to 2030: a simulation study based on a nationwide cohort
1 General Office of the Institute of Clinical Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China 2 National Clinical ...
BMJ9d
Right ventricle’s road to recovery: remodelling after chronic thromboembolic pulmonary hypertension intervention
Right heart failure is the most common cause of mortality in patients with pulmonary arterial hypertension.1 This includes chronic thromboembolic pulmonary hypertension (CTEPH), which through ...
BMJ14h
Use of intravenous magnesium to treat acute onset atrial fibrillation: a meta-analysis
Dr K M Ho, Intensive Care Unit, Royal Perth Hospital, Perth, WA 6000, Australia; kwok.ho{at}health.wa.gov.au Objectives: To assess the effects of intravenous magnesium on converting acute onset atrial ...
BMJ13d
Breaking new ground in treatment of coronary calcium
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
BMJ3d
Stimulation of collateral artery growth: travelling further down the road to clinical application
Dr S H Schirmer, Department of Cardiology, Academic Medical Centre, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Stephan.schirmer{at}uks.eu Collateral artery growth is a potent natural defence ...
BMJ4d
Preventable causative factors leading to hospital admission with decompensated heart failure
Objective To determine the distribution and importance of various factors, especially the preventable ones, that contribute to cardiac decompensation and subsequent hospital admission for heart ...
BMJ1d
14 Time to TAVI: streamlining the outpatient pathway to treatment
Introduction Transcatheter Aortic Valve Implantation (TAVI) is an established treatment option for severe aortic stenosis (AS), with over 5000 procedures performed in the UK in 2019. Given the high ...
BMJ1d
Chocolate consumption and risk of cardiovascular diseases: a meta-analysis of prospective studies
1 The Affiliated Luohu Hospital, Shenzhen University Health Science Center, Shenzhen, China Objective Studies investigating the impact of chocolate consumption on cardiovascular disease (CVD) have ...
BMJ4d
Pericardial diseases in patients with hypothyroidism
Correspondence to Dr. Allan L Klein, Center for the Diagnosis and Treatment of Pericardial Diseases, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA ; kleina{at}ccf.org ...
BMJ3d
Rationale and design of a randomised trial of intravenous iron in patients with heart failure
Correspondence to Dr Ian Ford, University of Glasgow Robertson Centre for Biostatistics, Glasgow G12 8QQ, UK; ian.ford{at}glasgow.ac.uk Methods IRONMAN is a prospective, randomised, open-label, ...
BMJ5d
Prognostic value of cardiac troponin in chronic stable heart failure: a systematic review
1 Department of Hospital Medicine, Cleveland Clinic, Cleveland, Ohio, USA 2 Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA 3 Heart and ...
BMJ4d
Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine
Department of Pharmacology, CV Therapeutics, Inc, Palo Alto, California, USA Correspondence to: Dr Luiz Belardinelli Department of Pharmacological Sciences, CV ...